ALL COMPANIES

HNC-364 is a small molecule MAO-B inhibitor, targeting motor impairment by preventing dopamine breakdown, thus increasing dopamine levels in the...

Legicon (a LD/CD/entacapone pump) combines a COMT inhibitor with a dopamine precursor to treat motor impairment by improving the effectiveness...

DopaFuse (LD/CD)  is a dopamine precursor delivered as a small molecule to manage motor impairment by restoring dopamine levels in...

PIMS-703 is an inhaled levodopa formulation, delivering a dopamine precursor as a small molecule for treating "OFF" episodes in Parkinson’s...

A-Dopamine is a small molecule dopamine receptor agonist that targets motor impairment by directly stimulating dopamine receptors to mimic dopamine’s...

AZ-009 (apomorphine) is a small molecule dopamine receptor agonist, used to treat motor impairment and "OFF" episodes by stimulating dopamine...

KDT-3594 is a dopamine receptor agonist that addresses motor impairment by enhancing dopamine receptor activity, thereby improving motor function in...

Pramipexole ER (CTC-413) is a small molecule that acts as a dopamine receptor agonist and NK-1 receptor antagonist to treat...

Mesdopetam (IRL-790) is a small molecule dopamine receptor antagonist targeting dyskinesia in Parkinson’s patients. By blocking certain dopamine receptors, it...